GITR
Latest round
- Series A
Last raised
- Apr 2015
Total raised
- $2.5M
Investors
- 1
About GITR
GITR Inc. develops therapies to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.
Who invested in GITR
1 investor across 2 rounds
See all investors in GITR
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GITR
Who invested in GITR?
GITR has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GITR raised?
GITR has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GITR last raise money?
GITR's most recent round on record is a Series A, in Apr 2015.
What does GITR do?
GITR is a healthcare company.
Where is GITR headquartered?
GITR is headquartered in Cambridge, US.
Which VCs invest in companies like GITR?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at GITR's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like GITR? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.